Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.

OBJECTIVES: To assess whether drug-induced suppression of the plasma viral load is associated with selective differential distribution of virus-specific CD8 T cells between the blood and secondary lymphoid organs. METHODS: HIV-specific CD8 T lymphocyte responses were quantified in matched peripheral...

Full description

Bibliographic Details
Main Authors: Oxenius, A, Yerly, S, Ramirez, E, Phillips, R, Price, D, Perrin, L
Format: Journal article
Language:English
Published: 2001
_version_ 1826256932957061120
author Oxenius, A
Yerly, S
Ramirez, E
Phillips, R
Price, D
Perrin, L
author_facet Oxenius, A
Yerly, S
Ramirez, E
Phillips, R
Price, D
Perrin, L
author_sort Oxenius, A
collection OXFORD
description OBJECTIVES: To assess whether drug-induced suppression of the plasma viral load is associated with selective differential distribution of virus-specific CD8 T cells between the blood and secondary lymphoid organs. METHODS: HIV-specific CD8 T lymphocyte responses were quantified in matched peripheral blood and lymph node samples from seven patients starting treatment shortly after infection, who received antiretroviral therapy (ART) for a median of 14 months. Cells recovered from samples were subjected to IFN-gamma ELISPOT analysis. A series of synthetic peptides corresponding to previously characterized cytotoxic T lymphocyte epitopes restricted by HLA I molecules present in each patient were used as antigens, together with appropriate positive and negative controls. RESULTS: HIV-specific CD8 T lymphocyte responses were found in six of the seven patients. The observed frequencies of HIV-specific CD8 T lymphocytes and the pattern of epitope recognition was identical within the two compartments. These results also confirm the observation that functional HIV-specific CD8 T cells are preserved on ART in most patients initiating treatment at the time of primary HIV-1 infection. CONCLUSION: This investigation demonstrated that patterns of antigenic immunodominance as well as frequencies of HIV-specific CD8 T lymphocytes are similar in blood and lymphoid tissue compartments in HIV-infected individuals. These findings support current approaches to the identification of HIV-specific CD8 T lymphocyte reactivity based on leukocytes isolated from blood even in patients with ART-induced suppression of viral load.
first_indexed 2024-03-06T18:10:07Z
format Journal article
id oxford-uuid:02bb7952-7648-4d85-b866-22467bf7fdd6
institution University of Oxford
language English
last_indexed 2024-03-06T18:10:07Z
publishDate 2001
record_format dspace
spelling oxford-uuid:02bb7952-7648-4d85-b866-22467bf7fdd62022-03-26T08:42:16ZDistribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:02bb7952-7648-4d85-b866-22467bf7fdd6EnglishSymplectic Elements at Oxford2001Oxenius, AYerly, SRamirez, EPhillips, RPrice, DPerrin, LOBJECTIVES: To assess whether drug-induced suppression of the plasma viral load is associated with selective differential distribution of virus-specific CD8 T cells between the blood and secondary lymphoid organs. METHODS: HIV-specific CD8 T lymphocyte responses were quantified in matched peripheral blood and lymph node samples from seven patients starting treatment shortly after infection, who received antiretroviral therapy (ART) for a median of 14 months. Cells recovered from samples were subjected to IFN-gamma ELISPOT analysis. A series of synthetic peptides corresponding to previously characterized cytotoxic T lymphocyte epitopes restricted by HLA I molecules present in each patient were used as antigens, together with appropriate positive and negative controls. RESULTS: HIV-specific CD8 T lymphocyte responses were found in six of the seven patients. The observed frequencies of HIV-specific CD8 T lymphocytes and the pattern of epitope recognition was identical within the two compartments. These results also confirm the observation that functional HIV-specific CD8 T cells are preserved on ART in most patients initiating treatment at the time of primary HIV-1 infection. CONCLUSION: This investigation demonstrated that patterns of antigenic immunodominance as well as frequencies of HIV-specific CD8 T lymphocytes are similar in blood and lymphoid tissue compartments in HIV-infected individuals. These findings support current approaches to the identification of HIV-specific CD8 T lymphocyte reactivity based on leukocytes isolated from blood even in patients with ART-induced suppression of viral load.
spellingShingle Oxenius, A
Yerly, S
Ramirez, E
Phillips, R
Price, D
Perrin, L
Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.
title Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.
title_full Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.
title_fullStr Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.
title_full_unstemmed Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.
title_short Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.
title_sort distribution of functional hiv specific cd8 t lymphocytes between blood and secondary lymphoid organs after 8 18 months of antiretroviral therapy in acutely infected patients
work_keys_str_mv AT oxeniusa distributionoffunctionalhivspecificcd8tlymphocytesbetweenbloodandsecondarylymphoidorgansafter818monthsofantiretroviraltherapyinacutelyinfectedpatients
AT yerlys distributionoffunctionalhivspecificcd8tlymphocytesbetweenbloodandsecondarylymphoidorgansafter818monthsofantiretroviraltherapyinacutelyinfectedpatients
AT ramireze distributionoffunctionalhivspecificcd8tlymphocytesbetweenbloodandsecondarylymphoidorgansafter818monthsofantiretroviraltherapyinacutelyinfectedpatients
AT phillipsr distributionoffunctionalhivspecificcd8tlymphocytesbetweenbloodandsecondarylymphoidorgansafter818monthsofantiretroviraltherapyinacutelyinfectedpatients
AT priced distributionoffunctionalhivspecificcd8tlymphocytesbetweenbloodandsecondarylymphoidorgansafter818monthsofantiretroviraltherapyinacutelyinfectedpatients
AT perrinl distributionoffunctionalhivspecificcd8tlymphocytesbetweenbloodandsecondarylymphoidorgansafter818monthsofantiretroviraltherapyinacutelyinfectedpatients